Decreasing Medication Requirements for Juvenile Dermatomyositis

SSS research data analyst Jesse Wilkerson and principal scientist Marjo Smith were among the authors of a poster at the 2018 American College of Radiology Annual Meeting that described an evaluation of initial therapies on treatment outcomes for children with juvenile dermatomyositis (a disease that causes skin rash and muscle inflammation and weakness). Results showed initial pulse intravenous methylprednisolone therapy and prednisone in combination with methotrexate reduced requirements for future treatment. Other authors of the poster included researchers from the National Institute of Environmental Health Sciences, Tokyo Women’s Medical University, Cincinnati Children’s Hospital Medical Center, IWK Health Centre and Dalhousie University, Medical University of South Carolina, and the National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Read more about SSS research activities in our online publication SSS Update.